Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$34.7 million.

  • Standard Biotools' Net Income towards Common Stockholders fell 2876.61% to -$34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.2 million, marking a year-over-year decrease of 280.26%. This contributed to the annual value of -$184.9 million for FY2024, which is 14766.8% down from last year.
  • Per Standard Biotools' latest filing, its Net Income towards Common Stockholders stood at -$34.7 million for Q3 2025, which was down 2876.61% from -$33.5 million recorded in Q2 2025.
  • Over the past 5 years, Standard Biotools' Net Income towards Common Stockholders peaked at -$9.4 million during Q4 2021, and registered a low of -$76.3 million during Q1 2022.
  • Over the past 5 years, Standard Biotools' median Net Income towards Common Stockholders value was -$26.0 million (recorded in 2025), while the average stood at -$29.3 million.
  • As far as peak fluctuations go, Standard Biotools' Net Income towards Common Stockholders crashed by 30582.16% in 2022, and later soared by 7786.58% in 2023.
  • Over the past 5 years, Standard Biotools' Net Income towards Common Stockholders (Quarter) stood at -$9.4 million in 2021, then tumbled by 121.07% to -$20.8 million in 2022, then rose by 4.56% to -$19.9 million in 2023, then crashed by 71.27% to -$34.1 million in 2024, then fell by 1.81% to -$34.7 million in 2025.
  • Its Net Income towards Common Stockholders was -$34.7 million in Q3 2025, compared to -$33.5 million in Q2 2025 and -$26.0 million in Q1 2025.